Renal insufficiency
Chronic renal failure (CRF) refers to a slowly progressive renal impairment caused by various kidney diseases, which eventually leads to uremia and complete loss of renal function, causing a series of clinical symptoms and a clinical syndrome consisting of biochemical, endocrine and other metabolic disorders. The interval from the onset of the primary disease to the onset of renal insufficiency can be several years to more than ten years. Chronic renal failure is a serious stage of renal insufficiency.
-
Site of disease:
kidney -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Hyperuric acid metabolism lethargy sleepiness blood pressure drop chronic renal insufficiency -
Concurrent disease:
Related Drugs
Allopurinol Tablets
Indication: 1. Primary and secondary hyperuricemia, especially hyperuricemia caused by excessive uric acid production; 2. Patients with recurrent or chronic gout; 3. Tophi; 4. Uric acid kidney stones and/or uric acid nephropathy; 5. Hyperuricemia with renal insufficiency.
Manufacturer:
Matrix Laboratories (Xiamen) Ltd.
Sodium Polystyrene Sulfonate Powder
Indication: Potassium-lowering drug. Used for hyperkalemia in acute and chronic renal insufficiency.
Compound Amino Acid Injection (9AA)
Indication: For parenteral support in patients with acute and chronic renal insufficiency; severe renal failure caused by major surgery, trauma or sepsis, as well as acute and chronic renal failure.
Compound Amino Acid Injection (9AA)
Indication: For parenteral support in patients with acute and chronic renal insufficiency; severe renal failure caused by major surgery, trauma or sepsis, as well as acute and chronic renal failure.
Manufacturer:
Livzon Pharmaceutical Grouping Limin Pharmaceutical FACTORY
Compound Amino Acid Injection (9AA)
Indication: For parenteral support in patients with acute and chronic renal insufficiency; severe renal failure caused by major surgery, trauma or sepsis, as well as acute and chronic renal failure.
Compound Amino Acid Injection (9AA)
Indication: For parenteral support in patients with acute and chronic renal insufficiency; severe renal failure caused by major surgery, trauma or sepsis, as well as acute and chronic renal failure.
Manufacturer:
Shijiazhuang No.4 Pharmaceutical Co., Ltd.
Compound Amino Acid Injection (9AA)
Indication: For parenteral support in patients with acute and chronic renal insufficiency; severe renal failure caused by major surgery, trauma or sepsis, as well as acute and chronic renal failure.
Manufacturer:
Wuhan Jiu'an Pharmaceutical Co., Ltd.
Compound Amino Acid Injection (9AA)
Indication: For parenteral support in patients with acute and chronic renal insufficiency; severe renal failure caused by major surgery, trauma or sepsis, as well as acute and chronic renal failure.
Manufacturer:
Xian Jingxi Double-Crane Pharmaceutical Co., Ltd.
Liuwei Dihuang Pills
Manufacturer:
ZHONGJING Wanxi Pharmacentical Co., Ltd.
Calcium Polystyrene Sulfonate Powder
Indication: Potassium-lowering drugs are mainly used to prevent and treat hyperkalemia in patients with acute and chronic renal insufficiency and renal failure.
Related Ingredients
-
Allopurinol list
315-30-0 -
L-Histidine list
71-00-1 -
L-Isoleucine list
73-32-5 -
L-Leucine list
61-90-5 -
L-Lysine Acetate Salt list
52315-92-1